BTIG Research Cuts Adaptive Biotechnologies (NASDAQ:ADPT) Price Target to $5.00

Adaptive Biotechnologies (NASDAQ:ADPT – Free Report) had its price objective decreased by BTIG Research from $6.00 to $5.00 in a research report sent to investors on Thursday morning, Benzinga reports. BTIG Research currently has a buy rating on the stock. Several other equities research analysts have also recently weighed in on ADPT. JPMorgan Chase & […]

Related Keywords

Chad , ,Jpmorgan Chase Co ,Adaptive Biotechnologies Company Profile ,Financial Services Group Inc ,Group Plc ,Vident Investment Advisory ,Nasdaq ,Adaptive Biotechnologies Corporation ,Commonwealth Equity Services ,Goldman Sachs Group ,Adaptive Biotechnologies ,Free Report ,Moderate Buy ,Get Free Report ,Equity Services ,General Group Plc ,Services Group ,Investment Advisory ,Biotechnologies Corporation ,Adaptive Biotechnologies Daily ,